Skip to main content

Table 2 Laboratory parameters

From: Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study)

  Pitavastatin Pravastatin
  Baseline After 6 months Baseline After 6 months
Total cholesterol, mg/dl 202 ± 67 154 ± 22* 225 ± 21 185 ± 16*
LDL cholesterol, mg/dl 150 ± 21 80 ± 16*† 142 ± 24 103 ± 18*
HDL cholesterol, mg/dl 52 ± 12 52 ± 11 54 ± 15 55 ± 13
Triglyceride, mg/dl 134 ± 35 107 ± 52 167 ± 63 135 ± 71
AST, IU/l 28 ± 13 26 ± 5 34 ± 18 32 ± 13
ALT, IU/l 27 ± 17 25 ± 9 29 ± 15 30 ± 12
γ-GTP, IU/l 34 ± 19 38 ± 28 79 ± 89 76 ± 84
CK, IU/l 77 ± 31 85 ± 26 95 ± 53 108 ± 63
High-sensitive CRP, μg/l 2,883 ± 4,176 3,581 ± 8,445 1,747 ± 2,239 3,928 ± 5,025
Hemoglobin A1c, % 5.8 ± 0.8 5.9 ± 0.7 5.4 ± 0.5 5.5 ± 0.4
Insulin, μU/ml 7.0 ± 4.7 6.7 ± 3.5 5.4 ± 2.9 4.7 ± 2.6
  1. LDL: low density lipoprotein, HDL: high density lipoprotein, AST: aspartate aminotransferase, ALT: alanine aminotransferase, CRP: C-reactive protein, CK: creatinine phosphokinase, *p < 0.05 vs baseline, p < 0.05 vs pravastatin.